ERFE and obesity due to melanocortin 4 receptor deficiency: In human studies, subjects with obesity and type 2 diabetes (T2D) showed lower serum levels than healthy lean subjects, and myonectin levels were inversely associated with indicators of metabolic risk (e.g., high body mass index (BMI), TG, LDL-C, VAT, and IR) [18].